FI103117B1 - Menetelmä terapeuttisesti käyttökelpoisten 2,4- ja 2,5-bis-tetratsolyylipyridiinien valmistamiseksi - Google Patents
Menetelmä terapeuttisesti käyttökelpoisten 2,4- ja 2,5-bis-tetratsolyylipyridiinien valmistamiseksiInfo
- Publication number
- FI103117B1 FI103117B1 FI920460A FI920460A FI103117B1 FI 103117 B1 FI103117 B1 FI 103117B1 FI 920460 A FI920460 A FI 920460A FI 920460 A FI920460 A FI 920460A FI 103117 B1 FI103117 B1 FI 103117B1
- Authority
- FI
- Finland
- Prior art keywords
- bis
- tetrazolylpyridines
- preparation
- therapeutically useful
- hydroxylase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4103372 | 1991-02-05 | ||
| DE4103372 | 1991-02-05 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI920460A0 FI920460A0 (fi) | 1992-02-03 |
| FI920460A FI920460A (fi) | 1992-08-06 |
| FI103117B FI103117B (fi) | 1999-04-30 |
| FI103117B1 true FI103117B1 (fi) | 1999-04-30 |
Family
ID=6424383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI920460A FI103117B1 (fi) | 1991-02-05 | 1992-02-03 | Menetelmä terapeuttisesti käyttökelpoisten 2,4- ja 2,5-bis-tetratsolyylipyridiinien valmistamiseksi |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US5482953A (fi) |
| EP (1) | EP0498334B1 (fi) |
| JP (1) | JPH0559041A (fi) |
| KR (1) | KR100214797B1 (fi) |
| AT (1) | ATE193288T1 (fi) |
| AU (1) | AU650511B2 (fi) |
| CA (1) | CA2060622A1 (fi) |
| CZ (1) | CZ283006B6 (fi) |
| DE (1) | DE59209838D1 (fi) |
| DK (1) | DK0498334T3 (fi) |
| ES (1) | ES2146581T3 (fi) |
| FI (1) | FI103117B1 (fi) |
| GR (1) | GR3033536T3 (fi) |
| HR (1) | HRP940840B1 (fi) |
| HU (1) | HUT61295A (fi) |
| IE (1) | IE920368A1 (fi) |
| IL (1) | IL100860A (fi) |
| MX (1) | MX9200492A (fi) |
| NO (1) | NO180446C (fi) |
| NZ (1) | NZ241505A (fi) |
| PT (1) | PT498334E (fi) |
| YU (1) | YU9492A (fi) |
| ZA (1) | ZA92788B (fi) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ305460B6 (cs) * | 2013-05-06 | 2015-10-07 | Contipro Biotech S.R.O. | Způsob přípravy esteru 2-oxoglutarátu, přípravek obsahující ester 2-oxoglutarát a jeho použití |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3432094A1 (de) * | 1984-08-31 | 1986-03-06 | Hoechst Ag, 6230 Frankfurt | Ester der pyridin-2,4- und -2,5- dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase |
| DE3703962A1 (de) * | 1987-02-10 | 1988-08-18 | Hoechst Ag | Pyridin-2,4- und 2,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen |
| US5238948A (en) * | 1987-02-10 | 1993-08-24 | Hoechst Aktiengesellschaft | Pyridine-2,4- and -2,5-dicarboxylic acid derivatives and medicaments based on these compounds |
| DE3703963A1 (de) * | 1987-02-10 | 1988-08-18 | Hoechst Ag | Pyridin-2,4- und 2,,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben, sowie arzneimittel auf basis dieser verbindungen |
| DE3703959A1 (de) * | 1987-02-10 | 1988-08-18 | Hoechst Ag | Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen |
| EP0353668B1 (de) * | 1988-08-04 | 1994-10-19 | Hoechst Aktiengesellschaft | Verbessertes Verfahren zur Herstellung von N,N-Bis(alkoxyalkyl)-pyridin -2,4-dicarbonsäurediamiden |
| JPH02178263A (ja) * | 1988-12-27 | 1990-07-11 | Kaken Pharmaceut Co Ltd | アザアズレン誘導体、その製造法およびそれを有効成分とする抗アレルギー剤および抗炎症剤 |
| DE3924093A1 (de) * | 1989-07-20 | 1991-02-07 | Hoechst Ag | N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung |
| FR2655801B1 (fr) * | 1989-12-08 | 1992-03-13 | Charbonnages De France | Procede et dispositif de transmission de signaux video en milieu confine. |
| ZA91291B (en) * | 1990-01-16 | 1991-09-25 | Hoechst Ag | Di(nitroxyalkyl)amides of pyridine-2,4-and-2,5-dicarboxylic acids,a process for the preparation thereof,and the use thereof |
| DE4020570A1 (de) * | 1990-06-28 | 1992-01-02 | Hoechst Ag | 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung |
-
1992
- 1992-01-30 YU YU9492A patent/YU9492A/sh unknown
- 1992-02-01 KR KR1019920001589A patent/KR100214797B1/ko not_active IP Right Cessation
- 1992-02-03 DK DK92101709T patent/DK0498334T3/da active
- 1992-02-03 IL IL10086092A patent/IL100860A/en not_active IP Right Cessation
- 1992-02-03 FI FI920460A patent/FI103117B1/fi active
- 1992-02-03 DE DE59209838T patent/DE59209838D1/de not_active Expired - Fee Related
- 1992-02-03 AT AT92101709T patent/ATE193288T1/de not_active IP Right Cessation
- 1992-02-03 PT PT92101709T patent/PT498334E/pt unknown
- 1992-02-03 NZ NZ241505A patent/NZ241505A/en unknown
- 1992-02-03 ES ES92101709T patent/ES2146581T3/es not_active Expired - Lifetime
- 1992-02-03 EP EP92101709A patent/EP0498334B1/de not_active Expired - Lifetime
- 1992-02-04 NO NO920462A patent/NO180446C/no not_active IP Right Cessation
- 1992-02-04 CZ CS92309A patent/CZ283006B6/cs not_active IP Right Cessation
- 1992-02-04 ZA ZA92788A patent/ZA92788B/xx unknown
- 1992-02-04 CA CA002060622A patent/CA2060622A1/en not_active Abandoned
- 1992-02-04 AU AU10724/92A patent/AU650511B2/en not_active Ceased
- 1992-02-04 MX MX9200492A patent/MX9200492A/es unknown
- 1992-02-04 IE IE036892A patent/IE920368A1/en not_active Application Discontinuation
- 1992-02-04 HU HU9200336A patent/HUT61295A/hu unknown
- 1992-02-04 JP JP4018627A patent/JPH0559041A/ja active Pending
-
1994
- 1994-01-21 US US08/183,786 patent/US5482953A/en not_active Expired - Fee Related
- 1994-10-26 HR HR940840A patent/HRP940840B1/xx not_active IP Right Cessation
-
1995
- 1995-06-05 US US08/465,326 patent/US5614537A/en not_active Expired - Fee Related
-
2000
- 2000-05-31 GR GR20000401228T patent/GR3033536T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU588826B2 (en) | Esters of pyridine-2,4- and 2,5-dicarboxylic acid as medicaments for the inhibition of proline hydroxylase and lysine hydroxylase | |
| NO940789D0 (no) | Quinolinkarboksylsyrederivater, deres fremstilling og anvendelse | |
| ATE162800T1 (de) | Inhibitoren mit zweifacher wirkung | |
| AU657166B2 (en) | Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace | |
| NO944430D0 (no) | 4-mercaptoacetylamino-[2Åbenzazepinon(3)-derivater, og anvendelse som enkefalinaseinhibitorer | |
| NO178026C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,4- og 2,5-substituerte pyridin-N-oksider | |
| MY104354A (en) | Non-peptidic renin inhibitors | |
| FI103117B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 2,4- ja 2,5-bis-tetratsolyylipyridiinien valmistamiseksi | |
| DE3887916D1 (de) | Schaltung zum automatischen Regeln des Verstärkung-Bandbreite-Produktes von Operationsverstärkern. | |
| NO910163L (no) | Fremgangsmaate for fremstilling og anvendelse av pyridin-2,4- og 2,5-dikarboksylsyredi-(nitroksyalkyl)amid. | |
| AU1516892A (en) | Novel 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors | |
| AP9400608A0 (en) | "New nicotinic acid derivative". | |
| DK0379288T3 (da) | Fremgangsmåde og mellemprodukter for isopropyl 3S-amino-2R-hydroxyalkanoater | |
| MX9704739A (es) | Monomeros de 3,3-(disustituido)ciclohexan-1-ona y compuestos relacionados. |